ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.355
-0.035 (-2.52%)
Nov 2, 2026, 2:07 PM EST - Market open
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $191.22 million as of November 2, 2026. It is the 20,672nd most valuable company in the world and the 3,589th biggest in the United States. Its market cap has decreased by 33.99% in one year.
Market Cap
191.22M
Enterprise Value
74.90M
1-Year Change
-33.99%
Global Rank
Country Rank
#3,589 United States
Category
ChartMarket Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has increased from $94.98M to $191.22M, an increase of 101.33%. That is a compound annual growth rate of 5.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 191.22M | -10.14% |
| Dec 31, 2025 | 212.80M | -22.19% |
| Dec 31, 2024 | 273.49M | 70.20% |
| Dec 29, 2023 | 160.69M | -39.20% |
| Dec 30, 2022 | 264.31M | -53.63% |
| Dec 31, 2021 | 569.95M | 170.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protalix BioTherapeutics | 208.68M |
| Artiva Biotherapeutics | 204.85M |
| Palisade Bio | 202.15M |
| Cartesian Therapeutics | 196.36M |
| Precision BioSciences | 194.87M |
| Alpha Cognition | 190.34M |
| Compugen | 187.55M |
| Upstream Bio | 186.77M |